Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease

A Goyal, A Verma, N Dubey, J Raghav… - Journal of Food …, 2022 - Wiley Online Library
Neurodegenerative disorders (NDs) are a cluster of progressive, severe, and disabling
disorders that affect millions of people worldwide and are on the surge. These disorders are …

[HTML][HTML] On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective

Z Nouri, S Fakhri, FF El-Senduny, N Sanadgol… - Biomolecules, 2019 - mdpi.com
As a group of progressive, chronic, and disabling disorders, neurodegenerative diseases
(NDs) affect millions of people worldwide, and are on the rise. NDs are known as the …

[HTML][HTML] Neuroprotective effects of pomegranate juice against Parkinson's disease and presence of ellagitannins-derived metabolite—urolithin A—in the brain

M Kujawska, M Jourdes, M Kurpik, M Szulc… - International journal of …, 2019 - mdpi.com
Pomegranate juice is a rich source of ellagitannins (ETs) believed to contribute to a wide
range of pomegranate's health benefits. While a lot of experimental studies have been …

[HTML][HTML] Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson's disease

RL Jayaraj, S Azimullah, KA Parekh, SK Ojha… - Heliyon, 2022 - cell.com
Citronellol, a monoterpene found in the essential oils of Cymbopogo plants has been
reported to possess various biological properties. In the present study, we investigated the …

[HTML][HTML] Behavioral tests in neurotoxin-induced animal models of Parkinson's disease

EM Prasad, SY Hung - Antioxidants, 2020 - mdpi.com
Currently, neurodegenerative diseases are a major cause of disability around the world.
Parkinson's disease (PD) is the second-leading cause of neurodegenerative disorder after …

Naringenin: its chemistry and roles in neuroprotection

AV Atoki, PM Aja, TS Shinkafi, EN Ondari… - Nutritional …, 2024 - Taylor & Francis
According to epidemiological research, as the population ages, neurological illnesses are
becoming a bigger issue. Despite improvements in the treatment of these diseases, there …

Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of …

X Liu, W Liu, C Wang, Y Chen, P Liu, T Hayashi… - Physiology & …, 2021 - Elsevier
Silybum marianum (L.) Gaertn has been widely used to obtain a drug for the treatment of
hepatic diseases. Silibinin (silybin), a flavonoid extracted and isolated from the fruit of S …

[HTML][HTML] Evidence for oxidative pathways in the pathogenesis of PD: are antioxidants candidate drugs to ameliorate disease progression?

A Leathem, T Ortiz-Cerda, JM Dennis… - International journal of …, 2022 - mdpi.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder that arises due to a
complex and variable interplay between elements including age, genetic, and …

[HTML][HTML] Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the gut–brain–skin axis

YR Woo, YJ Han, HS Kim, SH Cho, JD Lee - International Journal of …, 2020 - mdpi.com
Rosacea is a common chronic cutaneous inflammatory disorder. Recently, patients with
rosacea were identified as having a higher risk of developing various comorbidities such as …

[HTML][HTML] Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease

N Kumari, S Anand, K Shah, NS Chauhan, NK Sethiya… - Molecules, 2023 - mdpi.com
Neurological ailments, including stroke, Alzheimer's disease (AD), epilepsy, Parkinson's
disease (PD), and other related diseases, have affected around 1 billion people globally to …